Lo Francis's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Jan 14, 2026
- Accession no.
- 0001780660-26-000003
- Filed
- Jan 14, 2026
- Trade date
- Jan 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.41M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lo FrancisCIK 0001780660 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +36,650 | $7.80 | +$285,870 | 352,628 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +7,723 | $12.14 | +$93,757.22 | 360,351 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +21,002 | $8.46 | +$177,676.92 | 381,353 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseAcquired | +14,215 | $3.99 | +$56,717.85 | 395,568 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −79,590 | $17.73 | −$1,411,130.7 | 315,978 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −36,650 | $0.00 | $0 | 75,500 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −7,723 | $0.00 | $0 | 177,615 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −21,002 | $0.00 | $0 | 87,074 | Direct | |
| Jan 12, 2026 | Common Stock | MOption exerciseDisposed | −14,215 | $0.00 | $0 | 90,641 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.